≡

Monoclonal Antibody to Matrix Metalloproteinase 14 (MMP14)

MMP-X1; MT1-MMP; MTMMP1; Membrane Inserted; Membrane-type matrix metalloproteinase 1; Membrane-type-1 matrix metalloproteinase

  • Product No.MAC056Hu22
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceMonoclonal antibody preparation
  • HostMouse
  • Potency (Clone Number)n/a
  • Ig Isotype IgG
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Immunogen n/a
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid
  • Concentration1mg/mL
  • Organism Species Moren/a
  • ApplicationsWB; IHC; ICC; IP.
    If the antibody is used in flow cytometry, please check FCM antibodies.
  • Downloadn/a
  • UOM 20µl100µl 200µl 1ml 10ml
  • FOB US$ 111  US$ 259  US$ 370  US$ 925  US$ 3700 
    For more details, please contact local distributors!

SPECIFITY

The antibody is a mouse monoclonal antibody raised against MMP14. It has been selected for its ability to recognize MMP14 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cancer Research Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer Aacrjournals: Source
Anticancer Research Matrix metalloproteinase-2 and -14 in p16-Positive and -Negative HNSCC after Exposure To 5-FU and Docetaxel In Vitro Pubmed:25202075
Endocrine GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes PubMed: 25743265
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC056Hu03 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
RPC056Hu02 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
RPC056Hu01 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
EPC056Hu62 Eukaryotic Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
EPC056Hu61 Eukaryotic Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
APC056Hu01 Active Matrix Metalloproteinase 14 (MMP14) Cell culture; Activity Assays.
PAC056Hu01 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) IHC
PAC056Hu02 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB,IHC,ICC/IF
MAC056Hu22 Monoclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB; IHC; ICC; IP.
SEC056Hu ELISA Kit for Matrix Metalloproteinase 14 (MMP14) Enzyme-linked immunosorbent assay for Antigen Detection.
CMC056Hu Multiplex Assay Kit for Matrix Metalloproteinase 14 (MMP14) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
LMC056Hu Multiplex Assay Kit for Matrix Metalloproteinase 14 (MMP14) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.